Similar articles

• Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.

  Sonett JR, Suntharalingam M, Edelman MJ, Patel AB, Gamliel Z, Doyle A, Hausner P, Krasna M. Sonett JR, et al. Ann Thorac Surg. 2004 Oct;78(4):1200-5; discussion 1206. doi: 10.1016/j.athoracsur.2004.04.085. Ann Thorac Surg. 2004. PMID: 15464470 Review.
• [Adjuvant treatment for early stages of non-small-cell lung carcinoma (NSCLC)].

  Papadakis E. Papadakis E. Rev Pneumol Clin. 2001 Nov;57(5 Pt 2):S25-8. Rev Pneumol Clin. 2001. PMID: 11924238 Review. French. No abstract available.
• [Current approaches to the use of radiotherapy in patients with non-small-cell lung cancer].

  Goldobenko GV, Kanaev SV. Goldobenko GV, et al. Vopr Onkol. 1998;44(5):623-8. Vopr Onkol. 1998. PMID: 9884730 Review. Russian. No abstract available.
• [Role of carboplatin in the treatment of lung cancer].

  Bréchot JM. Bréchot JM. Bull Cancer. 2000 Aug;87 Spec No:34-9. Bull Cancer. 2000. PMID: 11082721 Review. French.
• [Radiotherapy and integrated treatment in carcinoma of the lung].

  Bottero G, Novella V, Spinoglio G. Bottero G, et al. Minerva Med. 1988 Apr;79(4):275-9. Minerva Med. 1988. PMID: 2835711 Italian.